InvestorsHub Logo
Followers 470
Posts 23607
Boards Moderated 0
Alias Born 02/05/2004

Re: newflow post# 125897

Monday, 02/27/2017 8:14:50 PM

Monday, February 27, 2017 8:14:50 PM

Post# of 130513
the 4 investment assets aren't even owned by SeD Biomed

their targeted assets...

Target Assets: SeD Biomed proposes to invest in one or more of the following biomedical assets described below and thereafter invest such biomedical assets into Amarantus.

Asset Name Description

1.Flavonoid Compound Composition for treating neurological disorders such as Alzheimer's Disease (Medical Food)
2.Clorinated Myrectin Shuts down kinases linked to cancer
3.Praesidium Natural mosquito repellent
4.Path-way Anti-Pathogenic Solution Broad spectrum antimicrobial compound

SeD Biomed currently has not acquired any of the abovementioned biomedical assets, the acquisition of which is still subject to negotiation, appropriate due diligence and the signing of definitive agreement(s).


*** mosquito repellent - really?